14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:OPXA
Delisted

Opexa Therapeutics Fund Predictions

$0.97
+0 (+0%)
At Close: Jan 16, 2018
Currently predicting for Mon, 24 Jun 2024

OPXA Predictions History

6 years ago
Victor.Li.10341 predicted that OPXA for 2017-09-05 is going $0.89 (1.36%)

Rank:

6 years ago
JuanC Villegas predicted that OPXA for 2017-09-05 is going $0.86 (1.34%)

6 years ago
JS predicted that OPXA for 2017-09-05 is going $0.86 (0.99%)

6 years ago
JuanC Villegas predicted that OPXA for 2017-07-14 is going $0.84 (-2.66%)

6 years ago
JS predicted that OPXA for 2017-07-14 is going $0.86 (-0.69%)

6 years ago
Brett predicted that OPXA for 2017-07-14 is going $1.00 (15.61%)

Rank:

6 years ago
JS predicted that OPXA for 2017-07-13 is going $0.83 (-4.05%)

6 years ago
Brett predicted that OPXA for 2017-07-13 is going $1.02 (14.59%)

Rank:

6 years ago
Jenny.j.9181 predicted that OPXA for 2017-07-06 is going $0.0300 (-96.54%)

Rank:

7 years ago
JS predicted that OPXA for 2016-12-12 is going $1.29 (6.61%)

Click to get the best stock tips daily for free!

About Opexa Therapeutics

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. The company’s lead product candidate is Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS. It is also developing OPX-212 as an autologous T-cell immunotherapy t... OPXA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT